The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Aug. 28, 2019
Applicant:
Academy of Military Medical Sciences, Beijing, CN;
Inventors:
Xinbo Zhou, Beijing, CN;
Yanming Wang, Beijing, CN;
Song Li, Beijing, CN;
Wu Zhong, Beijing, CN;
Shiyong Fan, Beijing, CN;
Dian Xiao, Beijing, CN;
Junhai Xiao, Beijing, CN;
Zhibing Zheng, Beijing, CN;
Xingzhou Li, Beijing, CN;
Yunde Xie, Beijing, CN;
Ruiyuan Cao, Beijing, CN;
Xiaokui Wang, Beijing, CN;
Assignee:
Academy of Military Medical Sciences, Beijing, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61K 31/337 (2006.01); A61K 31/4745 (2006.01); A61K 31/537 (2006.01); A61K 31/5517 (2006.01); A61K 31/704 (2006.01); A61K 38/07 (2006.01); A61K 47/54 (2017.01); A61P 35/00 (2006.01); C07C 237/04 (2006.01); C07D 207/452 (2006.01); C07D 233/94 (2006.01); C07D 307/71 (2006.01); C07D 333/44 (2006.01); C07D 403/04 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6811 (2017.08); A61K 31/337 (2013.01); A61K 31/4745 (2013.01); A61K 31/537 (2013.01); A61K 31/5517 (2013.01); A61K 31/704 (2013.01); A61K 38/07 (2013.01); A61K 47/545 (2017.08); A61K 47/6803 (2017.08); A61K 47/6809 (2017.08); A61P 35/00 (2018.01); C07C 237/04 (2013.01); C07D 207/452 (2013.01); C07D 233/94 (2013.01); C07D 307/71 (2013.01); C07D 333/44 (2013.01); C07D 403/04 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01);
Abstract
The present application relates to a linker containing arylnitro, an antibody-drug conjugate the linker and use of the linker, as well as a pharmaceutical composition comprising the antibody-drug conjugate and use of the antibody-drug conjugate for treatment and/or prevention of a disease